Danish pharmaceutical company Novo Nordisk has inked a deal with a
US medical device manufacturer that will extend the use of insulin
cartridges from autoinjectors to external insulin pumps.
UCB subsidiary Celltech has joined forces with the University of
Durham and another UK-based company to develop an unusual approach
to treating cancer using magnetic fields.
Bayer stockholders have cleared the way for the spin-off of
chemical unit Lanxess, with voters holding 99.66 per cent of the
company's capital stock supporting the split.
FMC BioPolymer is making progress in its collaboration with
BioProgress and Harro Hoefliger on a machine to produce its
recently-acquired NROBE tablet coating technology.
US drug company VIVUS as been granted a US patent relating to a new
drug delivery technology that makes it possible to spray drugs onto
the skin and have them taken up into the blood.
German, US and Canadian researchers have discovered a gene and six
mutations that cause symptoms associated with Parkinson's disease
and other neurodegenerative disorders.
Italian firm Chemi is moving production of the nutraceutical
ingredient phosphatidylserine to its pharmaceutical actives plant
in Brazil, allowing it to increase capacity and become more
competitive on price.
Nanotechnology for molecular targeting and drug delivery is set to
become a trillion-dollar industry with the drug sector's economic
and technological leadership key to the growth of the technology.
The ingredients division of Danish company Chr Hansen pulled in a
DKK 369 million (€49m) profit for the fiscal year on sales of DKK
3.4 billion (€460m), a slight dip on the previous year on rising
costs.
US drug delivery company Zengen has announced that its consumer
health subsidiary InnoZen has launched another over-the-counter
(OTC) pharmaceutical in oral film strip format, a delivery vehicle
that is being pursued by a number of...
In the race to develop therapeutics based on RNA interference,
Alnylam Pharmaceuticals has claimed a first with the publication of
a study showing in vivo RNAi-mediated gene silencing in
mammals by a method that potentially can be...
The march towards multidrug therapy of asthma has caused Italy's
Zambon to pull out of a research project aimed at developing new
inhaler formulations of the steroid budesonide and bronchodilator
formoterol.
US drug delivery company Emisphere Technologies reported promising
results last week with an oral formulation of insulin that could do
away with the need for injections in people with diabetes.
The European Molecular Biology Laboratory (EMBL) has joined forces
with a Taiwanese company Abnova, to develop a high-throughput
system for making monoclonal antibodies (MAbs).
A pioneering research project could pave the way for more effective
drug treatments for diseases including cancer, parasitic, bacterial
and viral diseases by visualising, in detail, membrane proteins
that have the potential to be...
Drug giant Pfizer has completed its purchase of UK-based drug
delivery company Meridica in a move that it says will bolster its
activities in allergy and respiratory medicine.
Lactose specialist Borculo Domo has teamed up with Univar to ramp
up its presence in the Scandinavian pharmaceutical market, part of
a concerted effort to improve its standing internationally.
A new approach to outwit resistance to antibiotics has been
discovered by a team of researchers who hope to apply this
knowledge to form new strategies and targets to combat
drug-resistant bacteria ubiquitous in both hospital settings...
Galapagos Genomics are set to receive additional milestone payments
of up to $40 million (€30.9 million) after its osteoporosis
discovery program with Wyeth Pharmaceuticals resulted in the US
drug gaints successfully selecting novel...
US company Spherix has made the first sale of its Naturlose
sweetener to a company in the pharmaceutical sector, since the
products was cleared for this application last December.
US drug delivery company SCOLR Pharma, announced it has filed a
provisional patent application utilizing the company's patented
amino acid technology for the Controlled Delivery Technology (CDT)
extended release form of ondansetron.
Researchers from medical charity Cancer Research UK have discovered
a new gene that protects against lung cancer, according to a study
published today in the journal Proceedings of the National Academy
of Sciences..
A tiny pressure sensor already sold in the automotive industry
could improve the efficacy of pumps used to deliver drugs from
implanted reservoirs, according to one of the scientists behind the
project.
US researchers have revealed the results of a study that show an
enzyme that normally alters the activity of other protein molecules
in cells may also help prevent lung cancer.
The safety hazards of reconstituting toxic drugs has been addressed
by Baxa, who have launched a dual purpose needle that prevents
environmental contamination that can occur during the process of
changing needles.
UK cellulose film specialist BioProgress has won another round in
its patent dispute with Stanelco Fibre Optics over the use of
radiofrequency welding to make polymer capsules.
Researchers have used engineered stem cells to zero in on tumours
to become part of the supporting tissue. They can then act as
vehicles for drugs that are pumped into the cancer, sparing normal
tissue.
Dow Chemical has renewed a collaboration with the University of
Texas at Austin (UT Austin) in the US aimed at developing a new
technology to improve the solubility and bioavailability of
candidate drugs.
A one-dose, microsphere formulation of azithromycin is as effective
as several days' treatment with other drugs for respiratory tract
infections (RTIs), according to new clinical data.
Emulsions are widely used in the formulation of pharmaceuticals,
cosmetics and foods, and researchers are continually striving to
increase the complexity of emulsions as a delivery vehicle.
A new therapeutic technique based on a small molecule working in
tandem with a larger protein has been shown to block accumulation
of the brain-clogging amyloid protein seen in Alzheimer's disease,
raising the possibility of...
Bioalliance Pharma, a pharmaceutical company focused on the field
of drug resistance, revealed results of a study that indicated a
new formulation of miconazole administered as a bioadhesive
extended release buccal tablet was more...
Researchers have identified a protein that protects the brain from
the destructive effects of Alzheimer's disease, protecting brain
cells by blocking another toxic protein that contributes to the
disease process
US company Sontra Medical has successfully completed the first
tests of a novel technology that allows vaccines to be applied
topically to the skin, rather than delivered through a needle.
Preliminary data suggest the method is as...
OctoPlus, a drug delivery and development company, and InnoCore
Technologies, a supplier of biodegradable polymeric drug delivery
systems, announced a joint collaboration to develop and market a
novel injectable drug delivery platform.
BioProgress, a developer of film strips and cellulose-based
capsules for drug and vitamin delivery, is increasing its
international presence, signing its first agreement for a line of
products for the Chinese market.
A class of drug, which is currently used to fight respiratory tract
infections, has demonstrated pharmacological features and potential
antibacterial drug activity that may prove effective against
Tuberculosis, which is currently...
Nobex has partnered with Biocon of India to accelerate its project
to develop an oral formulation of insulin, to provide a more
patient-friendly alternative to current injectable products for
diabetes.
A new technology that could revolutionise vaccine delivery by
eliminating the need for refrigeration has been given UK government
funding in a project to deliver immunisations to the developing
world.
The road to a new treatment for stroke is littered with the remains
of failed projects, so any data suggesting that a drug has activity
in this indication should be greeted with cautious optimism at
best. But AstraZeneca has joined...
Drug developer 3M has been given the go ahead to manufacture,
assemble and import investigational medicinal products (IMP) for
clinical trials involving human use in the UK, writes Wai Lang
Chu.
Pre-school youngsters with type I diabetes can be treated as
successfully with insulin pumps as with daily injections,
researchers at the Indiana University School of Medicine report.
Researchers in the US believe the discovery of a technique, which
once applied to an enzyme that degrades anti-cancer drugs in
humans, may improve such drugs' design and effectiveness.
Drug delivery company SCOLR Pharma has signed a deal to manufacture
its candidate decongestant product based on pseudoephedrine,
keeping it on track to start clinical trials early next year.
Children around the world at risk of malaria took a step closer to
having a protective vaccine with the reporting of encouraging new
data on a candidate developed by GlaxoSmithKline Biologicals.
Research into the causes of muscle wasting in diseases such as
cancer and diabetes have thrown up a new potential drug target,
according to US researchers, who report their findings in Cell (15
October issue).
Australia's Benitec, a specialist in gene silencing technologies
based on RNA interference (RNAi), has broadened its patent estate
by licensing a technology from Stanford University in the US that
could overcome the problems...
Novel approaches to administering drugs took a step forward after
Aradigm announced positive trial results in its Intraject
needle-free delivery system, which paves the way for a viable
alternative to the standard needle injection.
